First Foundation Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,157
Closed -$251K 422
2023
Q1
$251K Sell
2,157
-499
-19% -$55.9K 0.01% 324
2022
Q4
$301K Buy
2,656
+47
+2% +$5.16K 0.01% 304
2022
Q3
$210K Buy
+2,609
New +$221K 0.01% 344
2022
Q2
Sell
-4,132
Closed -$528K 413
2022
Q1
$528K Buy
4,132
+480
+13% +$52.5K 0.02% 251
2021
Q4
$490K Sell
3,652
-692
-16% -$99.4K 0.02% 268
2021
Q3
$594K Buy
4,344
+524
+14% +$66.1K 0.02% 254
2021
Q2
$408K Buy
3,820
+356
+10% +$34.2K 0.02% 315
2021
Q1
$311K Buy
3,464
+488
+16% +$45.8K 0.01% 334
2020
Q4
$275K Buy
+2,976
New +$266K 0.01% 347

Other funds holding DXCM

First Foundation Advisors's DXCM Position: Q2 2023 in Review

First Foundation Advisors sold out of DexCom (DXCM) in Q2 2023, closing a stake of 2,157 shares — an estimated $251K sold.

First Foundation Advisors first reported a position in DXCM in Q4 2020 and held it in 9 quarters. The position peaked at $594K in Q3 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • First Foundation Advisors reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • First Foundation Advisors sold 2,157 DexCom shares in Q2 2023, an estimated $251K.
  • First Foundation Advisors first reported a position in DexCom in Q4 2020 and held it in 9 quarters.
  • First Foundation Advisors's DexCom position peaked at $594K in Q3 2021.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on First Foundation Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.